Effects of chloroquine on viral infections: an old drug against today's diseases?

被引:875
作者
Savarino, A
Boelaert, JR
Cassone, A
Majori, G
Cauda, R
机构
[1] Univ Cattolica Sacro Cuore, Dept Infect Dis, Lab Viral Immunol, I-00168 Rome, Italy
[2] AZ St Jan Brugge, Infect Dis Unit, Brugge, Belgium
[3] Ist Super Sanita, Dept Infect Dis, I-00161 Rome, Italy
[4] Ist Super Sanita, Dept Parasitol, I-00161 Rome, Italy
关键词
D O I
10.1016/S1473-3099(03)00806-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Chloroquine is a 9-aminoquinoline known since 1934. Apart from its well-known antimalarial effects, the drug has interesting biochemical properties that might be applied against some viral infections. Chloroquine exerts direct antiviral effects, inhibiting pH-dependent steps of the replication of several viruses including members of the flaviviruses, retroviruses, and coronaviruses. Its best-studied effects are those against HIV replication, which are being tested in clinical trials. Moreover, chloroquine has immunomodulatory effects, suppressing the production/release of tumour necrosis factor alpha and interleukin 6. which mediate the inflammatory complications of several viral diseases. We review the available information on the effects of chloroquine on viral infections, raising the question of whether this old drug may experience a revival in the clinical management of viral diseases such as AIDS and severe acute respiratory syndrome, which afflict mankind in the era of globalisation.
引用
收藏
页码:722 / 727
页数:6
相关论文
共 61 条
[1]   Sarcoidosis [J].
Baughman, RP ;
Lower, EE ;
du Bois, RM .
LANCET, 2003, 361 (9363) :1111-1118
[2]   Concurrent infections and HIV pathogenesis [J].
Bentwich, Z ;
Maartens, G ;
Torten, D ;
Lal, AA ;
Lal, RB .
AIDS, 2000, 14 (14) :2071-2081
[3]  
BERNSTEIN HN, 1991, ANN OPHTHALMOL, V23, P292
[4]   OPHTHALMOLOGIC CONSIDERATIONS AND TESTING IN PATIENTS RECEIVING LONG-TERM ANTI-MALARIAL THERAPY [J].
BERNSTEIN, HN .
AMERICAN JOURNAL OF MEDICINE, 1983, 75 (1A) :25-34
[5]   Examination of potential inhibitors of hepatitis A virus uncoating [J].
Bishop, NE .
INTERVIROLOGY, 1998, 41 (06) :261-271
[6]  
Blau DM, 2001, ADV EXP MED BIOL, V494, P193
[7]   The boosting of didanosine by allopurinol permits a halving of the didanosine dosage [J].
Boelaert, JR ;
Dom, GM ;
Huitema, ADR ;
Beijnen, JH ;
Lange, JMA .
AIDS, 2002, 16 (16) :2221-2223
[8]   The potential place of chloroquine in the treatment of HIV-1-infected patients [J].
Boelaert, JR ;
Piette, J ;
Sperber, K .
JOURNAL OF CLINICAL VIROLOGY, 2001, 20 (03) :137-140
[9]   The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea [J].
Boelaert, JR ;
Sperber, K ;
Piette, J .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (12) :1531-1535
[10]   Antiretroviral treatment [J].
Boelaert, JR ;
Sperber, K .
LANCET, 1998, 352 (9135) :1224-1225